12,424 Shares in Colgate-Palmolive Company $CL Purchased by Talon Private Wealth LLC

Talon Private Wealth LLC acquired a new position in Colgate-Palmolive Company (NYSE:CL) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 12,424 shares of the company’s stock, valued at approximately $1,059,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. HighPoint Advisor Group LLC raised its holdings in shares of Colgate-Palmolive by 0.7% in the 4th quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock worth $1,255,000 after purchasing an additional 109 shares during the period. Clear Harbor Asset Management LLC grew its holdings in Colgate-Palmolive by 2.6% during the fourth quarter. Clear Harbor Asset Management LLC now owns 4,503 shares of the company’s stock valued at $356,000 after purchasing an additional 113 shares during the period. Moneta Group Investment Advisors LLC grew its holdings in Colgate-Palmolive by 0.7% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 15,506 shares of the company’s stock valued at $1,225,000 after purchasing an additional 114 shares during the period. Sunpointe LLC increased its position in Colgate-Palmolive by 4.0% in the fourth quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock worth $241,000 after buying an additional 117 shares during the last quarter. Finally, ANB Bank raised its stake in shares of Colgate-Palmolive by 1.7% in the first quarter. ANB Bank now owns 7,200 shares of the company’s stock valued at $614,000 after buying an additional 120 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Up 1.0%

Colgate-Palmolive stock opened at $92.87 on Wednesday. The stock has a market cap of $74.32 billion, a P/E ratio of 36.14, a PEG ratio of 4.84 and a beta of 0.33. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The firm’s fifty day moving average price is $90.87 and its 200-day moving average price is $89.26. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.03. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm’s revenue was up 8.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.91 earnings per share. Equities research analysts forecast that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be issued a $0.53 dividend. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 82.49%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. JPMorgan Chase & Co. upped their price target on Colgate-Palmolive from $96.00 to $104.00 and gave the company an “overweight” rating in a research report on Thursday, July 16th. Wells Fargo & Company boosted their price objective on Colgate-Palmolive from $92.00 to $95.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 8th. Citigroup upped their price objective on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Weiss Ratings upgraded shares of Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Finally, UBS Group lifted their target price on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock a “buy” rating in a research note on Thursday, July 16th. Twelve equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $97.82.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.